Welcome to the web pages of Harald Stenmark's group
Our group studies the molecular mechanisms that promote or suppress cancer, a disease that involves uncontrolled proliferation and invasiveness of specific cell types of the body. A description of our research can be found here.
Our group is member of a Centre of Excellence, Centre for Cancer Biomedicine (CCB), and a Centre for Research Based Innovation, Cancer Stem Cell Innovation Centre (CAST).
Department of Biochemistry, Institute for Cancer Research
The Norwegian Radium Hospital, Montebello, N-0310 Oslo, Norway
Telephone +47 22 78 18 18 (Stenmark), +47 22 78 12 69 (Dept. Secretary)
Email: stenmark@ulrik.uio.no
Print this page [21144 visits]Latest publications
Harald Stenmark's group
Ubiquitination of alpha 5 beta 1 integrin controls fibroblast migration through lysosomal degradation of fibronectin-integrin complexes
Dev Cell, 19 (1), 148-59
PubMed 20643357
A phosphatidylinositol 3-kinase class III sub-complex containing VPS15, VPS34, Beclin 1, UVRAG and BIF-1 regulates cytokinesis and degradative endocytic traffic
Exp Cell Res (in press)
PubMed 20643123
Autophagy contributes to therapy-induced degradation of the PML/RARA oncoprotein
Blood (in press)
PubMed 20574048
